Mustang Bio gets second 180-day window to fix Nasdaq bid price deficiency
Nasdaq granted the company until April 12, 2027 to lift its stock price back above $1.00 after it missed an earlier October 12 deadline.
SEC filing
Latest
1 story
Sign inSign in1 story
Nasdaq granted the company until April 12, 2027 to lift its stock price back above $1.00 after it missed an earlier October 12 deadline.
SEC filing